HUTCHMED (China) (HCM) Treasury Shares (2017 - 2026)
HUTCHMED (China) (HCM) posted quarterly Treasury Shares of $1.6 million for Q4 2025, down 24.76% year-over-year from $2.2 million in Q4 2024, and down 24.76% quarter-over-quarter from $2.2 million in Q4 2024.
HUTCHMED (China) (HCM) Treasury Shares (2017 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Treasury Shares for 8 consecutive years, with $1.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Treasury Shares fell 24.76% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (down 24.76% YoY), while the FY2025 annual figure was $15.4 million, down 63.34% from the prior year.
- Treasury Shares eased to $1.6 million in Q4 2025 per HCM's latest filing, from $2.2 million in the prior quarter.
- Across five years, Treasury Shares topped out at $16.9 million in Q2 2024 and bottomed at $1.0 million in Q4 2021.
- Historically, Treasury Shares has averaged $4.4 million across 5 years, with a median of $2.2 million in 2024.
- Annual changes were most pronounced in 2021 — Treasury Shares sank 78.36% — and 2022, when it surged 139.82%.
- HUTCHMED (China)'s Treasury Shares stood at $1.0 million in 2021, then soared by 139.82% to $2.5 million in 2022, then dropped by 10.05% to $2.3 million in 2023, then slipped by 4.6% to $2.2 million in 2024, then fell by 24.76% to $1.6 million in 2025.
- Business Quant data shows HCM's Treasury Shares at $1.6 million in Q4 2025, $2.2 million in Q4 2024, and $16.9 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Jun 30, 2026 | 3.26 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Jun 30, 2024 | 16.92 Mn |
| Jun 30, 2024 | 16.92 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Dec 31, 2020 | 4.83 Mn |
| Dec 31, 2020 | 4.83 Mn |
| Dec 31, 2018 | 731,000.00 |
| Dec 31, 2018 | 731,000.00 |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |